Literature DB >> 34060071

Melanoma pathology: new approaches and classification.

I Yeh1, B C Bastian1.   

Abstract

Cancer is caused by the accumulation of pathogenic alterations of the genome and epigenome that result in permanent changes that disrupt cellular homeostasis. The genes that become corrupted in this process vary among different tumour types, reflecting specific vulnerabilities and dependencies of the cell from which the cancer originated. This also applies to 'melanoma', a cancer that constitutes not one, but multiple diseases that can be separated based on their cell of origin, aetiology, clinical appearance and course, and response to treatment. In this article, we review the current classification of melanoma within distinct evolutionary pathways and the associated genetic alterations. In addition, we review the application of molecular diagnostics to the diagnosis of melanocytic tumours in the context of histopathological assessment.
© 2021 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2021        PMID: 34060071      PMCID: PMC9292921          DOI: 10.1111/bjd.20427

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   11.113


  95 in total

1.  Genomic Fusions in Pigmented Spindle Cell Nevus of Reed.

Authors:  Timothy VandenBoom; Victor L Quan; Bin Zhang; Erin M Garfield; Betty Y Kong; Maria C Isales; Elnaz Panah; Catherine Igartua; Timothy Taxter; Nike Beaubier; Kevin White; Pedram Gerami
Journal:  Am J Surg Pathol       Date:  2018-08       Impact factor: 6.394

2.  A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.

Authors:  Thomas Wiesner; Rajmohan Murali; Isabella Fried; Lorenzo Cerroni; Klaus Busam; Heinz Kutzner; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

3.  Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma.

Authors:  William G Hawkins; Klaus J Busam; Leah Ben-Porat; Katherine S Panageas; Daniel G Coit; David E Gyorki; David C Linehan; Mary S Brady
Journal:  Ann Surg Oncol       Date:  2005-03-03       Impact factor: 5.344

4.  Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.

Authors:  Jenny Li-Ying Huang; Oscar Urtatiz; Catherine D Van Raamsdonk
Journal:  Cancer Res       Date:  2015-06-25       Impact factor: 12.701

5.  Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.

Authors:  R Gutzmer; R A Herbst; S Mommert; P Kiehl; F Matiaske; A Rütten; A Kapp; J Weiss
Journal:  Hum Genet       Date:  2000-10       Impact factor: 4.132

6.  Prognosis and treatment of disseminated uveal melanoma.

Authors:  R Kath; J Hayungs; N Bornfeld; W Sauerwein; K Höffken; S Seeber
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

7.  TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms.

Authors:  Seungjae Lee; Raymond L Barnhill; Reinhard Dummer; James Dalton; Jianrong Wu; Alberto Pappo; Armita Bahrami
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

8.  Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.

Authors:  Peter Johansson; Lauren G Aoude; Karin Wadt; William J Glasson; Sunil K Warrier; Alex W Hewitt; Jens Folke Kiilgaard; Steffen Heegaard; Tim Isaacs; Maria Franchina; Christian Ingvar; Tersia Vermeulen; Kevin J Whitehead; Christopher W Schmidt; Jane M Palmer; Judith Symmons; Anne-Marie Gerdes; Göran Jönsson; Nicholas K Hayward
Journal:  Oncotarget       Date:  2016-01-26

9.  Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.

Authors:  Loren E Clarke; M B Warf; Darl D Flake; Anne-Renee Hartman; Steven Tahan; Christopher R Shea; Pedram Gerami; Jane Messina; Scott R Florell; Richard J Wenstrup; Kristen Rushton; Kirstin M Roundy; Colleen Rock; Benjamin Roa; Kathryn A Kolquist; Alexander Gutin; Steven Billings; Sancy Leachman
Journal:  J Cutan Pathol       Date:  2015-04-13       Impact factor: 1.587

View more
  3 in total

Review 1.  Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer.

Authors:  Shoichiro Ishizuki; Yoshiyuki Nakamura
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

Review 2.  Is Melanoma Progression Affected by Thyroid Diseases?

Authors:  Salvatore Ulisse; Enke Baldini; Daniele Pironi; Federica Gagliardi; Domenico Tripodi; Augusto Lauro; Sabino Carbotta; Danilo Tarroni; Matteo D'Armiento; Aldo Morrone; Flavio Forte; Flaminia Frattaroli; Severino Persechino; Teresa Odorisio; Vito D'Andrea; Eleonora Lori; Salvatore Sorrenti
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

3.  The Anticancer Potential of Doxycycline and Minocycline-A Comparative Study on Amelanotic Melanoma Cell Lines.

Authors:  Jakub Rok; Zuzanna Rzepka; Justyna Kowalska; Klaudia Banach; Artur Beberok; Dorota Wrześniok
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.